Evonik Industries stock (DE000EVNK013): German specialty chemicals leader for US portfolios

Evonik Industries AG, listed on the Frankfurt Stock Exchange, reported steady performance in its core specialty chemicals segments during the first quarter of 2026, with sales holding firm despite macroeconomic headwinds, according to Evonik IR as of 05/10/2026. The company, known for high-value additives and active ingredients, maintains a strong foothold in the US, where it generates significant revenue from animal nutrition and performance materials.

As of: 13.05.2026

By the editorial team – specialized in equity coverage.

Evonik Industries: core business model

Evonik Industries focuses on specialty chemicals that enable advanced applications across industries. The company divides its operations into three key segments: Nutrition & Care, which provides amino acids for animal feed and health products; Specialty Additives for coatings, plastics and inks; and Smart Materials including high-performance polymers. This model emphasizes high-margin, innovation-driven products over commodity chemicals, serving customers in pharmaceuticals, automotive and agriculture. Evonik's strategy prioritizes sustainability, with investments in bio-based materials and carbon capture technologies.

Founded in 2007 from the remnants of RAG, Evonik has evolved into a pure-play specialty chemicals firm. It employs around 22,000 people globally and reported €15.3 billion in sales for 2025, per its annual report published 03/15/2026. The business benefits from long-term customer contracts and R&D spending of about 5% of sales.

Main revenue and product drivers for Evonik Industries

Nutrition & Care contributes roughly 35% of revenue, driven by methionine for poultry and swine feed, a product where Evonik holds leading market share. US demand remains robust due to expanding livestock production. Specialty Additives, at 30%, powers the coatings industry with silica and polymer additives, benefiting from US infrastructure spending. Smart Materials rounds out the portfolio with polymers for 3D printing and lightweight composites used in electric vehicles.

In Q1 2026, group sales reached €3.8 billion, flat year-over-year but with EBITDA margins stable at 14%, according to Evonik's Q1 report as of 05/10/2026. Volume growth in North America offset price pressures in Europe.

Industry trends and competitive position

The specialty chemicals sector faces decarbonization pressures, with Evonik positioning itself through its "Green Agenda," targeting 100% renewable energy by 2030. Competitors like BASF and Dow offer broader portfolios, but Evonik's niche focus yields higher margins. In the US, Evonik's sites in Mobile, Alabama and Theodore, Alabama support local production of feed additives, reducing import reliance.

Market research from S&P Global dated 04/2026 projects 4% CAGR for specialty additives through 2030, driven by EV and sustainable packaging trends, where Evonik is active.

Why Evonik Industries matters for US investors

Evonik derives about 25% of sales from North America, with exposure to US agribusiness and automotive sectors. Its products underpin food security via animal nutrition and support the green transition in coatings. Listed as an ADR (EVKIF) on US OTC markets, it offers US investors access without direct DAX exposure. Currency translation benefits from a weaker euro have supported recent earnings.

Conclusion

Evonik Industries demonstrates resilience in specialty chemicals, with balanced segment performance and strategic US exposure. Ongoing sustainability initiatives and innovation pipelines position it amid industry shifts. Investors track Q2 results expected in early August 2026 for further insights into volume recovery.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.